ALLIFE Medicine Science and Technology

Allife Medicine Science and Technology is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative cell therapies. The company focuses on chimeric antigen receptor T-cell (CAR-T) and T-cell receptor (TCR-T) technologies to address unmet needs in oncology. Their pipeline includes candidates for hematological malignancies, such as B-cell lymphoma and multiple myeloma, as well as solid tumors like liver and pancreatic cancer. Allife Medicine utilizes a proprietary platform to engineer cells with enhanced precision, safety, and persistence in the tumor microenvironment. The company operates its own GMP-compliant manufacturing facilities to support clinical trials and future commercialization. By integrating advanced genetic engineering with robust manufacturing, Allife Medicine aims to provide accessible and effective immunotherapy solutions globally.